Navigation Links
Covidien supports NOSCAR US multicenter human trial
Date:7/8/2011

OAK BROOK, Ill., July 8, 2011 The Natural Orifice Surgery Consortium for Assessment and Research (NOSCAR), a joint effort of the American Society for Gastrointestinal Endoscopy (ASGE) and the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), is pleased to announce a grant from Covidien to support the U.S. multicenter human trial on transoral and transvaginal cholecystectomies (gallbladder removal) using Natural Orifice Translumenal Endoscopic Surgery (NOTES).

"NOSCAR is grateful to Covidien for supporting the NOTES human trial research and helping to advance this minimally invasive technique," said Steven D. Schwaitzberg, MD, NOSCAR Research Subcommittee Co-Chair.

Cholecystectomy, or gallbladder removal, is one of the most common surgeries in the U.S.; approximately 750,000 are performed annually. The NOSCAR study uses the mouth or vagina as routes to the gallbladder. Rather than making up to five incisions in the abdominal wall, tools are passed down the mouth and through a hole created in the stomach (transoral/transgastric) or through the vagina (transvaginal).

The prospective multicenter trial compares NOTES cholecystectomy versus conventional laparoscopic cholecystectomy. NOSCAR has granted funds to selected institutions to conduct these trials. Institutions participating in the trial have demonstrated a strong commitment to developing the basic science that forms the foundation of NOTES and have already performed human NOTES cases under an Institutional Review Board protocol; approximately 200 patients will be enrolled in the clinical trial.

"Covidien is dedicated to collaborating with the surgical community to drive the adoption of advanced minimally and non-invasive surgical techniques through well-designed, robust clinical studies," said Michael Tarnoff, M.D., Chief Medical Officer, Covidien. "NOTES may represent the next wave in minimally invasive surgery with significant potential to improve patient outcomes and reduce hospital stays. Covidien is pleased that its funding will support NOSCAR's efforts to ensure the most safe and effective development of NOTES procedures and techniques throughout the world."

"The human trials have already achieved very positive results and we now have a total of five institutions and 35 patients participating in the trial," said Michael L. Kochman, MD, NOSCAR Research Subcommittee Co-Chair.


'/>"/>

Contact: Anne Brownsey
abrownsey@asge.org
630-570-5635
American Society for Gastrointestinal Endoscopy
Source:Eurekalert

Related medicine news :

1. Nature Publishing Group supports ASCB Childcare Awards for scientist-parents at annual meeting
2. Latest data from Cedars-Sinai vaccine study supports immune targeting of brain tumors
3. Horizon Pharma supports fellows and students with AGA Abstract Prizes
4. Strong evidence supports prognostic value of circulating tumor cells in breast cancer
5. International Diabetes Federation supports surgery to treat diabetes
6. Autism Speaks supports new diagnostic code for individuals with autism with history of wandering
7. $1.9 million NIH grant supports research in the most common soft tissue tumor in children
8. GSA supports new US call for improved nutrition and physical activity
9. US Department of Defense supports study of brain, eye injuries in military personnel
10. Scientific evidence supports effectiveness of Chinese drug for cataracts
11. British Study Supports Mammograms for Some Women Under 50
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... Tarzana, CA (PRWEB) , ... April 29, 2016 , ... Melanoma is the deadliest type ... is to blame for the majority of skin cancer deaths. More than 10,000 people are ... average age at diagnosis is 62, it is the one of the most commonly diagnosed ...
(Date:4/29/2016)... ... April 29, 2016 , ... For those who skip ... meal to miss. That was among the many new lifestyle diet tips offered by ... Sharon Kleyne Hour® Power of Water® radio show. Bonny and Lawrence noted that because ...
(Date:4/29/2016)... ... April 29, 2016 , ... CURE ... entirely on patients with cancer, today announced that Lynne Malestic, RN, of Eisenhower ... 2016 CURE® Extraordinary Healer® for Oncology Nursing , which honors nurses who have ...
(Date:4/29/2016)... ... April 29, 2016 , ... International Dehydrated Foods, Inc. ... May 3 and 4 at the Doubletree by Hilton Hotel in Oak Brook, Illinois. ... marketing and applications technologies for protein ingredients. , At the seminar, IDF™ will offer ...
(Date:4/29/2016)... Wilmington, DE (PRWEB) , ... April 29, 2016 ... ... annual SMG Finance, which will be held May 16th to 18th at the ... all of the SMG managed facilities to collaborate on best practices in public ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 2016 Dr. ... und Stephen Schmidt werden ... ArisGlobal®, ein führender Anbieter cloudbasierter Softwarelösungen für ... dass neue Führungskräfte zum Team Sicherheit und ... vielfältige Erfahrungen mitbringen.  Dies wird die Geschäftseinheit ...
(Date:4/28/2016)... -- Dr. Vivek Ahuja , ... Ste phen Schmidt Join ... cloud-based software solutions for life sciences, today announced key new leaders ... of insight to a growing business.  This will bolster the company,s ... Phillips joined ArisGlobal in the position of Vice President - ...
(Date:4/28/2016)... Florida , April 28, 2016 ... the development of innovative peptide and gene-based immunotherapeutics and vaccines ... it will be presenting at the 3rd Annual Growth ... - 5 th , 2016 at Caesars Palace in Las Vegas, ... 8.00 am on Wednesday, May 4 th by Dr. ...
Breaking Medicine Technology: